Agilent Technologies, Inc. $A Shares Sold by Calamos Advisors LLC

Calamos Advisors LLC reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 3.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 163,570 shares of the medical research company’s stock after selling 6,642 shares during the period. Calamos Advisors LLC owned 0.06% of Agilent Technologies worth $22,257,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $27,000. Davis Capital Management acquired a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $28,000. Physician Wealth Advisors Inc. raised its position in shares of Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares during the last quarter. State of Wyoming acquired a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $35,000. Finally, SJS Investment Consulting Inc. raised its position in shares of Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after purchasing an additional 312 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on A. Morgan Stanley cut their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. UBS Group cut their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $155.00 to $160.00 in a research report on Monday, January 5th. Wells Fargo & Company cut their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Finally, Barclays cut their price target on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Trading Up 1.0%

Shares of A opened at $115.60 on Friday. The stock has a fifty day moving average of $117.25 and a two-hundred day moving average of $133.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The company has a market capitalization of $32.67 billion, a PE ratio of 25.52, a price-to-earnings-growth ratio of 2.41 and a beta of 1.30. Agilent Technologies, Inc. has a fifty-two week low of $104.10 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company’s revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were issued a $0.255 dividend. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s payout ratio is 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.